Day

July 23, 2026
Indian drug shares declined Wednesday following US President Trump’s tariff announcement. These proposed tariffs will significantly impact companies with substantial US revenue exposure. Analysts suggest investors should now focus on domestically oriented Indian pharmaceutical firms. The Nifty Pharma index saw a notable decrease, while the benchmark Nifty 50 also fell. Negotiations are expected given India’s...
Read More
Global investors show increased interest in India’s equity markets recently. Corporate earnings and economic performance have remained quite strong. Foreign investors are diversifying portfolios away from concentrated tech positions. India’s market may see a catch-up rally after recent underperformance. Banks and tourism are identified as attractive investment pockets within India.
Read More
Indo-MIM plans a ₹500 crore IPO for debt and corporate needs. The company will also raise ₹3,312 crore through an offer for sale. Its global market share in metal injection moulding is significant. Revenue and profit have shown strong annual growth in recent years. Risk-tolerant investors may consider this long-term opportunity.
Read More
Maharashtra State Electricity Distribution Co has appointed eight investment bankers for its proposed initial public offering. This significant issue could potentially raise between eight thousand and ten thousand crore rupees. The offering will mark the first-ever IPO by the Maharashtra government and a state-run discom. Mahavitaran, the brand under which MSEDCL operates, will be listed....
Read More
Indian markets experienced a decline on Wednesday due to global and geopolitical concerns. IndusInd Bank reported a significant profit increase while Eternal saw substantial net profit growth. BPCL, however, posted a considerable loss in the first quarter. Adani Green announced a moderate profit rise, and Dr Reddy’s profit declined. Several other companies like Infosys will...
Read More
Domestic equities declined as broad-based selling persisted across sectors. India VIX surged, reflecting heightened market volatility and investor fear. Analysts expect sideways trading with a negative bias due to global tensions. Foreign portfolio investors were net sellers, impacting market sentiment negatively. The Indian rupee fell to a two-month low as oil prices climbed.
Read More
India’s benchmark indices ended lower on Wednesday, as crude oil prices increased. The Nifty50 and Sensex experienced significant drops, falling below key levels. Midcap and smallcap stocks also saw declines, reflecting broad market weakness. Most sector indices ended in negative territory, except for FMCG and Auto. Brent crude oil prices rose, impacting investor sentiment across...
Read More
Asian shares advanced as regional chipmakers gained on artificial intelligence buildout expectations. Oil extended its rally after Houthi militants targeted Saudi Arabian tankers in the Red Sea. Alphabet Inc. raised its capital spending significantly, impacting US equity futures negatively. Investors are scrutinizing megacap earnings for AI return on investment signs. Geopolitical tensions and rising energy...
Read More
Foreign inflows into Indian government securities have begun to slow down. This moderation follows a strong surge in June driven by index inclusion expectations. Narrowing yield spreads between India and the US are now a key factor. Concerns over rupee weakness and delayed index decisions also contribute. Investors are reassessing the attractiveness of rupee-denominated assets.
Read More
Nestle India shares reached a record high after a strong June quarter performance. Revenue growth accelerated significantly year-on-year, reaching 25.2 percent. However, operating margins moderated sequentially due to increased advertising investments. Exports also showed steady growth, driven by market penetration and product additions. The company anticipates continued healthy demand supported by premiumization and innovation.
Read More

Text Widget

Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.

Our Cases